LRF maintains genome integrity by regulating the non-homologous end joining pathway of DNA repair
Xuesong Liu(Tianjin Institute of Pharmaceutical Research (China)), Pier Paolo Pandolfi(University of Turin)
Cited by 20
Related Papers
ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models
|Clinical Cancer Research|2007|770
Pten Dose Dictates Cancer Progression in the Prostate
|PLoS Biology|2003|667
Subtle variations in Pten dose determine cancer susceptibility
|Nature Genetics|2010|579
The PTEN–PI3K Axis in Cancer
|Biomolecules|2019|292
A metabolic prosurvival role for PML in breast cancer
|Journal of Clinical Investigation|2012|272